Skip to main navigation Skip to search Skip to main content

Long-term efficacy and safety of ustekinumab for Crohn's disease through the second year of therapy

  • W. J. Sandborn
  • , P. Rutgeerts
  • , C. Gasink
  • , D. Jacobstein
  • , B. Zou
  • , J. Johanns
  • , B. E. Sands
  • , S. B. Hanauer
  • , S. Targan
  • , S. Ghosh
  • , W. J.S. de Villiers
  • , J. F. Colombel
  • , B. G. Feagan
  • Birmingham

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Long-term efficacy and safety of ustekinumab for Crohn's disease through the second year of therapy'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science